Last updated on May 2020

Safety Tolerability and Efficacy of Cilofexor in Non-Cirrhotic Adults With Primary Sclerosing Cholangitis


Brief description of study

The primary objective of this study is to evaluate whether cilofexor reduces the risk of fibrosis progression among non-cirrhotic adults with primary sclerosing cholangitis (PSC).

Clinical Study Identifier: NCT03890120

Find a site near you

Start Over

Austin Health

Heidelberg, Australia
3.47miles
  Connect »

The Royal Melbourne Hospital

Parkville, Australia
4.79miles
  Connect »

The Alfred Hospital

Melbourne, Australia
6.21miles
  Connect »